Hilar Fat Infiltration: An Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma with Sunitinib First-Line Treatment

被引：0
|
作者：
Kammerer-Jacquet, Solene-Florence
Brunot, Angelique
Benasalah, Karim
Campillo-Gimenez, Boris
Lefort, Mathilde
Bayat, Sahar
Ravaud, Alain
Dupuis, Frantz
Yacoub, Mokrane
Verhoest, Gregory
Mathieu, Romain
Peyronnet, Benoit
Lespagnol, Alexandra
Mosser, Jean
Edeline, Julien
Laguerre, Brigitte
Bernhard, Jean-Christophe
Rioux-Leclercq, Nathalie
机构：
[1] Univ Hosp, Rennes, France
[2] Ctr Eugene Marquis, Rennes, France
[3] EHESP, Rennes, France
[4] Univ Hosp, Bordeaux, France
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
947
引用
收藏
页码：234A / 234A
页数：1
相关论文
共 50 条
  • [1] Hilar Fat Infiltration: An Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma with Sunitinib First-Line Treatment
    Kammerer-Jacquet, Solene-Florence
    Brunot, Angelique
    Benasalah, Karim
    Campillo-Gimenez, Boris
    Lefort, Mathilde
    Bayat, Sahar
    Ravaud, Alain
    Dupuis, Frantz
    Yacoub, Mokrane
    Verhoest, Gregory
    Mathieu, Romain
    Peyronnet, Benoit
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Bernhard, Jean-Christophe
    Rioux-Leclercq, Nathalie
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 234A - 234A
  • [2] Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment
    Kammerer-Jacquet, Solene-Florence
    Brunot, Angelique
    Bensalah, Karim
    Campillo-Gimenez, Boris
    Lefort, Mathilde
    Bayat, Sahar
    Ravaud, Alain
    Dupuis, Frantz
    Yacoub, Mokrane
    Verhoest, Gregory
    Peyronnet, Benoit
    Mathieu, Romain
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Bernhard, Jean-Christophe
    Rioux-Leclercq, Nathalie
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 603.e7 - 603.e14
  • [3] Sunitinib First-line Treatment in Metastatic Renal Cell Carcinoma: Costs and Effects
    Vuorinen, Riikka-Liisa
    Paunu, Niina
    Turpeenniemi-Hujanen, Taina
    Reunamo, Taina
    Jekunen, Antti
    Kataja, Vesa
    Sintonen, Harri
    Purmonen, Timo
    Kellokumpu-Lehtinen, Pirkko-Liisa
    [J]. ANTICANCER RESEARCH, 2019, 39 (10) : 5559 - 5564
  • [4] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Vazquez, Sergio
    Leon, Luis
    Fernandez, Ovidio
    Lazaro, Martin
    Grande, Enrique
    Aparicio, Luis
    [J]. ADVANCES IN THERAPY, 2012, 29 (03) : 202 - 217
  • [5] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Sergio Vázquez
    Luis León
    Ovidio Fernández
    Martín Lázaro
    Enrique Grande
    Luis Aparicio
    [J]. Advances in Therapy, 2012, 29 : 202 - 217
  • [6] Nomogram Predicting Prognosis in Metastatic Patients with Clear Cell Renal Cell Carcinoma Treated by First-Line Sunitinib
    Kammerer-Jacquet, Solene-Florence
    Dugay, Frederic
    Bensalah, Karim
    Brunot, Angelique
    Peyronnet, Benoit
    Mathieu, Romain
    Verhoest, Gregory
    Lefort, Mathilde
    Bayat, Sahar
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Dupuis, Frantz
    Yacoub, Mokrane
    Ravaud, Alain
    Bernhard, Jean-Christophe
    Belaud-Rotureau, Marc-Antoine
    Rioux-Leclercq, Nathalie
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 234A - 234A
  • [7] Nomogram Predicting Prognosis in Metastatic Patients with Clear Cell Renal Cell Carcinoma Treated by First-Line Sunitinib
    Kammerer-Jacquet, Solene-Florence
    Dugay, Frederic
    Bensalah, Karim
    Brunot, Angelique
    Peyronnet, Benoit
    Mathieu, Romain
    Verhoest, Gregory
    Lefort, Mathilde
    Bayat, Sahar
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Dupuis, Frantz
    Yacoub, Mokrane
    Ravaud, Alain
    Bernhard, Jean-Christophe
    Belaud-Rotureau, Marc-Antoine
    Rioux-Leclercq, Nathalie
    [J]. MODERN PATHOLOGY, 2017, 30 : 234A - 234A
  • [8] Economic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcinoma
    Remak, Edit
    Charbonneau, Claudie
    Negrier, Sylvie
    Kim, Sindy T.
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 3995 - 4000
  • [9] ECONOMIC EVALUATION OF SUNITINIB AS FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA IN COLOMBIA
    Prieto, V. A.
    Reyes, J. M.
    Lopez-Cabra, C.
    Diaz, J. A.
    Urrego-Novoa, J. R.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A149 - A149
  • [10] Economic evaluation of sunitinib as first-line treatment for metastatic renal cell carcinoma in Mexico
    Emilio, Mucino-Ortega
    Joaquin Federico, Mould-Quevedo
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (02): : 48 - 57
12345